Massmutual Trust Co. FSB ADV Purchases 593 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Massmutual Trust Co. FSB ADV grew its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 25.5% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 2,922 shares of the pharmacy operator’s stock after acquiring an additional 593 shares during the quarter. Massmutual Trust Co. FSB ADV’s holdings in Walgreens Boots Alliance were worth $65,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently modified their holdings of WBA. Pittenger & Anderson Inc. bought a new stake in Walgreens Boots Alliance during the first quarter worth $28,000. China Universal Asset Management Co. Ltd. grew its holdings in Walgreens Boots Alliance by 273.2% during the second quarter. China Universal Asset Management Co. Ltd. now owns 974 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 713 shares in the last quarter. Spotlight Asset Group Inc. bought a new stake in Walgreens Boots Alliance during the second quarter worth $28,000. Northwest Bank & Trust Co bought a new stake in Walgreens Boots Alliance during the second quarter worth $29,000. Finally, Milestone Investment Advisors LLC bought a new position in Walgreens Boots Alliance in the 1st quarter valued at $31,000. Institutional investors own 57.92% of the company’s stock.

Walgreens Boots Alliance Price Performance

WBA traded up $0.47 during trading on Friday, reaching $21.22. 11,981,829 shares of the company were exchanged, compared to its average volume of 10,457,213. The company’s 50-day moving average is $21.70 and its two-hundred day moving average is $26.76. The company has a market cap of $18.33 billion, a price-to-earnings ratio of -5.94, a P/E/G ratio of 1.24 and a beta of 0.80. The company has a quick ratio of 0.30, a current ratio of 0.63 and a debt-to-equity ratio of 0.29. Walgreens Boots Alliance, Inc. has a 12-month low of $20.00 and a 12-month high of $42.29.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, October 12th. The pharmacy operator reported $0.67 earnings per share for the quarter, missing analysts’ consensus estimates of $0.69 by ($0.02). The business had revenue of $35.42 billion during the quarter, compared to the consensus estimate of $34.81 billion. Walgreens Boots Alliance had a positive return on equity of 12.31% and a negative net margin of 2.21%. Walgreens Boots Alliance’s revenue was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.80 earnings per share. Research analysts forecast that Walgreens Boots Alliance, Inc. will post 3.34 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Tuesday, November 14th will be paid a $0.48 dividend. The ex-dividend date of this dividend is Monday, November 13th. This represents a $1.92 dividend on an annualized basis and a yield of 9.05%. Walgreens Boots Alliance’s dividend payout ratio is currently -53.78%.

Wall Street Analyst Weigh In

WBA has been the subject of a number of recent analyst reports. Mizuho reduced their price objective on Walgreens Boots Alliance from $31.00 to $25.00 and set a “neutral” rating for the company in a research note on Tuesday, October 10th. Evercore ISI reduced their price objective on Walgreens Boots Alliance from $26.00 to $21.00 in a research note on Wednesday, October 11th. Royal Bank of Canada reduced their price objective on Walgreens Boots Alliance from $29.00 to $26.00 and set a “sector perform” rating for the company in a research note on Friday, October 13th. Truist Financial dropped their price target on Walgreens Boots Alliance from $30.00 to $25.00 and set a “hold” rating on the stock in a research report on Wednesday, October 11th. Finally, JPMorgan Chase & Co. raised Walgreens Boots Alliance from a “neutral” rating to an “overweight” rating and upped their price target for the company from $27.00 to $30.00 in a research report on Monday, October 23rd. One research analyst has rated the stock with a sell rating, eight have given a hold rating and four have given a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $33.15.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.